(Q80715560)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17667959%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

title

Association of graded allele-specific changes in CYP2D6 function with imipramine dose requirement in a large group of depressed patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17667959%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

author name string

P W Schenk

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17667959%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

M A C van Fessem

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17667959%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

S Verploegh-Van Rij

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17667959%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

R A A Mathot

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17667959%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

T van Gelder

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17667959%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

A G Vulto

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17667959%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

M van Vliet

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17667959%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

J Lindemans

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17667959%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

J A Bruijn

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17667959%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

R H N van Schaik

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17667959%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

publication date

31 July 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17667959%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17667959%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17667959%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17667959%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

page(s)

597-605

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17667959%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.mp.4002057

2 January 2020

exact match

0 references

cites work

Invited review: the evolution of antidepressant mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002057

7 January 2021

Some aspects of genetic polymorphism in the biotransformation of antidepressants

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002057

7 January 2021

Allele-specific change of concentration and functional gene dose for the prediction of steady-state serum concentrations of amitriptyline and nortriptyline in CYP2C19 and CYP2D6 extensive and intermediate metabolizers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002057

7 January 2021

Pharmacogenetics and adverse drug reactions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002057

7 January 2021

Imipramine demethylation in vivo: Impact of CYP1A2, CYP2C19, and CYP3A4*

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002057

7 January 2021

The relationship between antidepressant response and tricyclic antidepressant plasma concentrations. A retrospective analysis of the literature using logistic regression analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002057

7 January 2021

Comprehensive analysis of the genetic factors determining expression and function of hepatic CYP2D6.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002057

7 January 2021

Assessment of the predictive power of genotypes for the in-vivo catalytic function of CYP2D6 in a German population

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002057

7 January 2021

Duplication of CYP2D6 predicts high clearance of desipramine but high clearance does not predict duplication of CYP2D6

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002057

7 January 2021

Cytochrome P450 2D6: overview and update on pharmacology, genetics, biochemistry

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002057

7 January 2021

CYP2D6 genotype: impact on adverse effects and nonresponse during treatment with antidepressants-a pilot study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002057

7 January 2021

The CYP2D6 poor metabolizer phenotype may be associated with risperidone adverse drug reactions and discontinuation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002057

7 January 2021

The association between cytochrome P450 2D6 genotype and prescription patterns of antipsychotic and antidepressant drugs in hospitalized psychiatric patients: a retrospective follow-up study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002057

7 January 2021

Impact of CYP2D6 intermediate metabolizer alleles on single-dose desipramine pharmacokinetics

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002057

7 January 2021

Elucidation of the genetic basis of the common 'intermediate metabolizer' phenotype for drug oxidation by CYP2D6

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002057

7 January 2021

Pharmacogenetic screening and therapeutic drugs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002057

7 January 2021

A rating scale for depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002057

7 January 2021

Genetic tests which identify the principal defects in CYP2C19 responsible for the polymorphism in mephenytoin metabolism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002057

7 January 2021

A polymorphic CfoI site in exon 6 of the human cytochrome P450 CYP2D6 gene detected by the polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002057

7 January 2021

Detection of CYP2D6*3 and 2D6*4 Allelic Variants by PCR-Restriction Fragment Length Polymorphism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002057

7 January 2021

CYP2D6 poor metabolizer status can be ruled out by a single genotyping assay for the -1584G promoter polymorphism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002057

7 January 2021

A novel intronic mutation, 2988G>A, with high predictivity for impaired function of cytochrome P450 2D6 in white subjects.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002057

7 January 2021

Ultrarapid metabolizers of debrisoquine: Characterization and PCR-based detection of alleles with duplication of the CYP2D6 gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002057

7 January 2021

Steady-state concentrations of imipramine and its metabolites in relation to the sparteine/debrisoquine polymorphism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002057

7 January 2021

Identification of a new variant CYP2D6 allele lacking the codon encoding Lys-281: possible association with the poor metabolizer phenotype

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002057

7 January 2021

Therapeutic drug monitoring of antidepressants and cytochrome p450 genotyping in general practice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002057

7 January 2021

Polymorphism of the cytochrome P450 CYP2D6 gene in a European population: characterization of 48 mutations and 53 alleles, their frequencies and evolution.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002057

7 January 2021

The prevalence of CYP2D6 and CYP2C19 genotypes in a population of healthy Dutch volunteers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002057

7 January 2021

Pilot study of the cytochrome P450-2D6 genotype in a psychiatric state hospital.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002057

7 January 2021

The impact of CYP2C19 and CYP2D6 genotypes on metabolism of amitriptyline in Japanese psychiatric patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002057

7 January 2021

Steady-state plasma concentrations of imipramine and desipramine in relation to S-mephenytoin 4'-hydroxylation status in Japanese depressive patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002057

7 January 2021

Excess fatality from desipramine and dosage recommendations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002057

7 January 2021

Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002057

7 January 2021

Identifiers

DOI

10.1038/SJ.MP.4002057

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17667959%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

1 reference